San Francisco Marin Medical Society Blog

Article References for August 2016 San Francisco Medicine

---

---

References cited for "Alzheimer’s and Anosognosia: Seeing the Stigma of Dementia" by Catherine Madison, MD

1. Chemistry World. July 3, 2014.
2. Muramoto, O. J Med Ethics. 2011 Jun;37(6):339-43
3. Irish M., Piolino, P. Br J Clin Psychol. 2015 May 27. doi: 10.1111/bjc.12090
4. Neurologia. 2016 Jun;31(5):296-304. doi: 10.1016/j.nrl.2015.03.006. Epub 2015 May 12

References cited for "A New Era in Acute Ischemic Stroke Therapy" by Alan Yee, MD

1. Powers, W.J., Derdeyn, C.P., Biller, J., et al. "2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals." Stroke. 2015:3020–35.
2. Solomon, N.A., Glick, H.A., Russo, C.J., Lee, J., Schulman, K.A. "Patient preferences for stroke outcomes." Stroke. 1994 Sep 1;25(9):1721–5.
3. "Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group." N Engl J Med. 1995 Dec 14;333(24):1581–7.
4. Hacke, W., Kaste, M., Fieschi, C., Toni, D., Lesaffre, E. "Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS)." JAMA. 1995.
5. Heuschmann, P.U., Berger, K., Misselwitz, B., et al. "Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality." strokeahajournalsorg.
6. Adeoye, O., Hornung, R., Khatri, P., Kleindorfer, D. "Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years." Stroke. 2011 Jul;42(7):1952–5.
7. Hacke, W., Kaste, M., Bluhmki, E., et al. "Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke." N Engl J Med. 2008 Sep 25;359(13):1317–29.
8. Sørensen, S.B., Barazangi, N., Chen, C., et al. "Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study." J Stroke Cerebrovasc Dis. 2016 May;25(5):1110–8.
9. Smith, W.S., Lev, M.H., English, J.D., et al. "Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA." Stroke. 2009 Dec;40(12):3834–40.
10. Zangerle, A., Kiechl, S., Spiegel, M., et al. "Recanalization after thrombolysis in stroke patients: predictors and prognostic implications." Neurology. 2007 Jan 2;68(1):39–44.
11. Furlan, A., Higashida, R., Wechsler, L., et al. "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism." JAMA. 1999 Dec 1;282(21):2003–11.
12. Ogawa, A., Mori, E., Minematsu, K., et al. "Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan." Stroke. 2007 Oct;38(10):2633–9.
13. Penumbra Pivotal Stroke Trial Investigators. "The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease." Stroke. 2009 Aug;40(8):2761–8.
14. Smith, W.S., Sung, G., Starkman, S., et al. "Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial." Stroke. 2005 Jul;36(7):1432–8.
15. Ciccone, A., Valvassori, L., Nichelatti, M., et al. "Endovascular treatment for acute ischemic stroke." N Engl J Med. 2013 Mar 7;368(10):904–13.
16. Broderick, J.P., Palesch, Y.Y., Demchuk, A.M., et al. "Endovascular therapy after intravenous t-PA versus t-PA alone for stroke." N Engl J Med. 2013 Mar 7;368(10):893–903.
17. Saver, J.L., Jahan, R., Levy, E.I., et al. "Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial." Lancet. 2012 Oct 6;380(9849):1241–9.
18. Nogueira, R.G., Lutsep, H.L., Gupta, R., et al. "Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial." Lancet. 2012 Oct 6;380(9849):1231–40.
19. Berkhemer, O.A., Fransen, P.S.S., Beumer, D., et al. "A randomized trial of intraarterial treatment for acute ischemic stroke." N Engl J Med. 2015 Jan 1;372(1):11–20.
20. Goyal, M., Demchuk ,A.M., Menon, B.K., et al. "Randomized assessment of rapid endovascular treatment of ischemic stroke." N Engl J Med. 2015 Mar 12;372(11):1019–30.
21. Campbell, B.C.V., Mitchell, P.J., Kleinig, T.J., et al. "Endovascular therapy for ischemic stroke with perfusion-imaging selection." N Engl J Med. 2015 Mar 12;372(11):1009–18.
22. Saver, J.L., Goyal, M., Bonafe, A., et al. "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke." N Engl J Med. 2015 Jun 11;372(24):2285–95.
23. Jovin, T.G., Chamorro, A., Cobo, E., et al. "Thrombectomy within 8 hours after symptom onset in ischemic stroke." N Engl J Med. 2015 Jun 11;372(24):2296–306.
24. https://clinicaltrials.gov/ct2/show/NCT02142283